Nov 17, 2017 - Alnylam (ALNY) has started rolling New Drug Application to the FDA for its RNAi candidate, patisiran.
Nov 16, 2017 - Sanofi has some upside.Ultragenyx’s MPS VII treatment approved by FDA.Capricor falls sharply despite promising data.
Nov 16, 2017 - Alnylam (ALNY) expects to achieve the profile of three marketed products by the end of 2020 and remains focused on development of its pipeline candidates.
Nov 15, 2017 - Sanofi reported weak Q3 2017 results.The market has been disappointed by the performance of the Diabetes franchise and by the downgrade of their long term guidance for this franchise.Despite a compell
Nov 15, 2017 - Barclays issues rating change for SNY
Nov 15, 2017 - Berkshire Hathaway's 13F stock portfolio value increased from $162B to $178B this quarter.Their largest three holdings are at ~40% of the entire portfolio.Berkshire Hathaway increased Apple, Monsanto,
Nov 14, 2017 - GSK regained top dog by net gains, while TEVJF led again by yield as calculated 11/13/17.The Healthcare sector is composed of ten component industries. The top 50 firms selected by yield for this writ
Nov 14, 2017 - Despite pricing pressure & competition, the diabetes market remains lucrative given the prevalence of the disease and demand for better treatments. Novo Nordisk (NVO) is a key player in this market.
Nov 14, 2017 - Alnylam's (ALNY) RNAi candidate, patisiran, has been granted accelerated assessment by the European Medicines Agency. The company expects to file new drug application by end of 2017.
Nov 13, 2017 - Weik Investment Services Inc Buys O'Reilly Automotive Inc, Schwab U.S. Broad Market, Schwab US Dividend Equity, Sells Advance Auto Parts Inc, Vanguard Total Stock Market, Pfizer Inc, Stocks: SCHB,SNY,DISCK,MDLZ,T,KHC,ORLY,SCHD,CW,SLB,KMPR,VZ, release date:Nov 13, 2017